Accessibility Menu

MediWound(FRA) M8W

Market Cap€143.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€10.70
-3.60%
-0.40Today

MediWound Financials at a Glance

Market Cap

€143.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€10.17

Net Income (TTM)

-€17.32

EPS (TTM)

-€1.38

P/E Ratio

-8.06

Dividend

€0.00

Beta (Volatility)

-0.07 (Low)

Price

€10.70

Volume

0

Open

€10.70

Previous Close

€10.70

Daily Range

€10.70 - €10.70

52-Week Range

€10.60 - €17.00

Estimated Earnings Date

N/A

M8W News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MediWound

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

Industry

Pharmaceuticals

Employees

121

CEO

Ofer Gonen

M8W Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-71.70%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-12.41%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€143.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.91M

Volume

0

Avg. Volume

139.97

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

MediWound Performance Analysis

MediWound annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 25,210,89225.4%
20232023-12-31EUR 17,283,998-31.4%
20242024-12-31EUR 18,694,8078.2%
20252025-12-31EUR 15,026,875-19.6%
MediWound annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -3.7426.9%
20232023-12-31EUR -0.69-81.6%
20242024-12-31EUR -2.81307.1%
20252025-12-31EUR -1.86-33.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€2.66

+0.5%

Gross Profit

€0.29

+0.2%

Gross Margin

10.90%

+0.5%

Market Cap

€143.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.37

N/A

Employees

121

N/A

Net Income

-€6.36

+0.5%

EBITDA

-€7.79

+1.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€12.14

+43.2%

Total Debt

€8.34

+1.1%

Accounts Receivable

€1.48

+0.3%

Inventory

€3.60

+1.1%

Long Term Debt

€7.53

+1.1%

Short Term Debt

€0.82

+1.2%

Return on Assets

-28.88%

+0.6%

Return on Invested Capital

19.29%

N/A

Free Cash Flow

-€8.69

+1.5%

Operating Cash Flow

-€7.77

+1.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About M8W

What is the current price of MediWound?

MediWound is trading at €10.70 per share.

What is the 52-week range for MediWound?

Over the past 52 weeks, MediWound has traded between €10.60 and €17.00.

How much debt does MediWound have?

As of the most recent reporting period, MediWound reported total debt of €8.34M.

How much cash does MediWound have on hand?

MediWound reported €3.80M in cash and cash equivalents in its most recent financial results.

What is MediWound’s dividend yield?

MediWound does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.